SD
Sashi Debsarma
About Sashi Debsarma
Data last updated:
Sashi Debsarma is a Ceo at Ubique Pharma Private Limited (since 2023). Ubique Pharma Private Limited reported revenue of ₹9.3 Lakh (FY 2025). Earlier, Sashi Debsarma was a Director at Uttam Asha Infrastructure Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ubique Pharma Private Limited U47721WB2023PTC260267 | Ceo | 20 May 2023 | 2023 | ₹9.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Uttam Asha Infrastructure Limited U74999WB2012PLC172846 | Director | 24 Jan 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sashi Debsarma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jaya Debsarma Barman | 10064878 | Ubique Pharma Private Limited | Director |
| Nisha Barman | 08923944 | Ubique Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sashi Debsarma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sashi Debsarma
Sashi Debsarma currently holds 1 directorship: Ubique Pharma Private Limited (Ceo, since 20 May 2023, revenue ₹9.3 Lakh (FY 2025)).
Sashi Debsarma was first appointed on 24 Jan 2012 as Director at Uttam Asha Infrastructure Limited. The most recent appointment on record is 20 May 2023 at Ubique Pharma Private Limited.
Sashi Debsarma held 1 earlier board appointment: Uttam Asha Infrastructure Limited (Director, from 24 Jan 2012).
The current boards of Sashi Debsarma's companies include Jaya Debsarma Barman (Ubique Pharma Private Limited), Nisha Barman (Ubique Pharma Private Limited).